BioMed Realty upgraded to Buy from Hold at KeyBanc KeyBanck upgraded BioMed Realty due to strong leasing execution, accretive investment activity, and the recent capital raise. Price target is $24.
News For BMR From The Last 14 Days
Check below for free stories on BMR the last two weeks.